These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management. Patnaik MM; Tefferi A Am J Hematol; 2023 Apr; 98(4):681-689. PubMed ID: 36601682 [TBL] [Abstract][Full Text] [Related]
4. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881 [TBL] [Abstract][Full Text] [Related]
5. Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes. Tiu RV; Sekeres MA Curr Opin Hematol; 2014 Mar; 21(2):131-40. PubMed ID: 24378705 [TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic/myeloproliferative neoplasms. Cazzola M; Malcovati L; Invernizzi R Hematology Am Soc Hematol Educ Program; 2011; 2011():264-72. PubMed ID: 22160044 [TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of MDS/MPN overlap syndromes. Hunter AM; Padron E Best Pract Res Clin Haematol; 2020 Sep; 33(3):101195. PubMed ID: 33038984 [TBL] [Abstract][Full Text] [Related]
8. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category. Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278 [TBL] [Abstract][Full Text] [Related]
9. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders? Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705 [TBL] [Abstract][Full Text] [Related]
10. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression. Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343 [TBL] [Abstract][Full Text] [Related]
11. An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T. Talati C; Padron E Curr Hematol Malig Rep; 2016 Dec; 11(6):425-433. PubMed ID: 27664113 [TBL] [Abstract][Full Text] [Related]
13. The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features. Orazi A; Germing U Leukemia; 2008 Jul; 22(7):1308-19. PubMed ID: 18480833 [TBL] [Abstract][Full Text] [Related]
14. Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview. Kuendgen A; Kasprzak A; Germing U Front Oncol; 2021; 11():778741. PubMed ID: 34869027 [TBL] [Abstract][Full Text] [Related]
15. Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study. Fei F; Jariwala A; Pullarkat S; Loo E; Liu Y; Tizro P; Ali H; Otoukesh S; Amanam I; Artz A; Ally F; Telatar M; Nakamura R; Marcucci G; Afkhami M Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337700 [TBL] [Abstract][Full Text] [Related]
16. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia. Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135 [TBL] [Abstract][Full Text] [Related]
17. Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes. Clara JA; Sallman DA; Padron E Cancer Biol Med; 2016 Sep; 13(3):360-372. PubMed ID: 27807503 [TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic and myeloproliferative disorders in children. Hasle H Curr Opin Pediatr; 2007 Feb; 19(1):1-8. PubMed ID: 17224655 [TBL] [Abstract][Full Text] [Related]
19. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Hasle H; Niemeyer CM; Chessells JM; Baumann I; Bennett JM; Kerndrup G; Head DR Leukemia; 2003 Feb; 17(2):277-82. PubMed ID: 12592323 [TBL] [Abstract][Full Text] [Related]